Search

Las investigaciones muestran que la terapia LIT, un tipo emergente de inmunoterapia, funciona en algunos pacientes con cáncer pulmonar de células no pequeñas.

… Wednesday, May 1, 2024 Hay evidencia de que un tipo emergente de inmunoterapia llamado terapia LIT podría ser exitoso en el tratamiento de tumores más sólidos . Una investigación publicada en Cancer Discovery demuestra que este tratamiento funciona en algunos pacientes con cáncer pulmonar de células

Doctors at MSK Kids, the dedicated pediatric service at Memorial Sloan Kettering Cancer Center (MSK), pioneered many advances for pediatric patients in 2022.

… Monday, January 30, 2023 Doctors at MSK Kids , the dedicated pediatric service at Memorial Sloan Kettering Cancer Center (MSK), pioneered many advances for pediatric patients in 2022. A combination of clinical trial findings and laboratory studies contributed to a greater understanding of the role that

New MSK research developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells.

… Monday, July 8, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells. MSK-developed

Meet Fiona and Stanley Druckenmiller, whose latest venture supports promising new avenues of research for experts at Memorial Sloan Kettering Cancer Center.

… Friday, January 1, 2021 Fiona and Stanley Druckenmiller know the value of a good investment. Throughout their successful careers in finance, the Druckenmillers have lived by a key tenet: Invest in the causes and people you believe in. A passion for economics and keen analytical skills guided them throughout

Official running program of Memorial Sloan Kettering Cancer Center sets new single-year fundraising record with every dollar raised going directly to cancer research.

… Wednesday, January 21, 2026 NEW YORK, January 21, 2026 — Fred’s Team, the official running program of Memorial Sloan Kettering Cancer Center (MSK), proudly announces a new single-year fundraising record: raising over $10 million for cancer research at MSK in 2025. This milestone, achieved during the

Cancers linked to HPV are on the rise. But only a little over half of all adolescents in the U.S. got the full series of vaccinations. In this Q&A, Chrisann Kyi talks about why it's so important for young people to get vaccinated.

… Thursday, September 27, 2018 Summary HPV-associated cancers are on the rise, but only about half of all adolescents in the United States have received the full series of shots. In this Q & A, Chrisann Kyi talks about why it’s so important for young people to get vaccinated. Update: On October 5, 2018

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.

… Friday, December 23, 2022 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2022 financial results today.

… Friday, April 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2022 financial results today: MSK generated an operating loss of $248.1 million for fiscal year 2022, which was driven in large part by inflationary pressures that contributed

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Friday, January 6, 2023 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Lisa DeAngelis Lisa DeAngelis Honored by Society of Neuro-Oncology with Creation of Excellence in Education Award Lisa DeAngelis, MD, Physician-In-Chief, Chief Medical Officer, and Scott

The research arm of Memorial Sloan Kettering was established to apply industrial techniques to the study of cancer.

… Thursday, August 27, 2015 Sloan and Kettering with Rendering of building, 1945 The Sloan Kettering Institute was built adjacent to Memorial Hospital. It has since expanded to additional buildings in the research corridor of Manhattan’s Upper East Side. Alfred P. Sloan said at the time, “The scientific